Please login to the form below

Not currently logged in
Email:
Password:

Just:: Health Communications becomes HAVAS Just::

Healthcare agency changes name one year after its acquisition by HAVAS Health

Havas JustJust:: Health Communications has changed its name to HAVAS Just:: following its acquisition by the HAVAS Health group in June last year.

The London-based agency became part of HAVAS to expand its global reach and tap into the group's in-market knowledge and expertise.

Lead by co-founders Emma Crozier and Jennie Talman, HAVAS Just:: continues to be managed by its existing senior team and reports to HAVAS Health's chief executive Donna Murphy.

The acquisition of Just:: was a “strategic investment in the PR space to further grow the HAVAS Health brand footprint in global markets”, according to Murphy.

She added that the past 12 months have been a success for the group, and has unified the network's “unique” approach to healthcare communications.

Commenting on the name change, Talman said: “We are proud to be part of HAVAS Health.

“We share the same passion and enthusiasm for the work and after a successful 12 months we are delighted to embrace HAVAS not only in spirit but also in name.”

Article by
Rebecca Clifford

1st July 2016

From: Marketing

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
wethepeople

wethepeople are bringing human appeal back to brand communications. Our approach allows us to create strategies, ideas and experiences that...

Latest intelligence

Report: Achieving launch excellence in the challenging healthcare markets of today
Our in-depth report is based on original data and expert interviews, which coupled with our own experience, ensures we give you the best recommendations for achieving launch success in challenging...
What is blockchain and why should i care - Richard Springham
Four Health - Emerging Technologies The power of blockchain lies in the fact it can prove that a unique event occurred at a certain time with out the need to...
NHS medicines optimisation milestone
Steve How, Paul Midgley and Oli Hudson, of the Wilmington Healthcare Consulting Team, explore the implications of Adalimumab’s recent European patent expiry...

Infographics